DKSH acquires Macau-based healthcare distributor Glory
With the acquisition, DKSH continues its strategic expansion in the industry by adding a direct presence in Macau to its pan-Asian coverage. With the move, DKSH is driving
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.
The randomized, double-blind study is the company’s second cancer therapy approved for clinical trials by the FDA, bolstering its platform approach to treating late stage solid-tumor cancers. The